Dr Gui-liang Chen, member of the Medical Technical Options Committee since 2008, is a chief pharmacist, and a full time deputy director at the Shanghai Institute for Food and Drug Control (SIFDC).
has been engaged in assessing the safety, efficacy and quality of inhalation products since 2002.
has no proprietary interest in alternatives or substitutes to ODSs, does not own stock in companies producing ODS or alternatives or substitutes to ODSs, and does not consult for organizations seeking to phase-out ODSs.
Gui-liang Chen's spouse works at a local hospital in Shanghai, and has no interest in matters before the Protocol.
Dr Chen works occasionally as a consultant to the China Government on matters related to the Montreal Protocol.
Travel to MTOC meetings is paid by UNEP's Ozone Secretariat.